Back

Impact of new definition on the prognosis of patients with pulmonary hypertension compared to classic definition

11 May 2024 (12:12 - 13:48)
Organised by: Logo
Congress Presentation Part of: ePosters in valvular and pulmonary 2 Pulmonary Hypertension HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor So-Young Lee

Seoul St. Marys Hospital, Seoul (Korea (Republic of))

4 More presentations in this session

Presentation thumbnail
Prognostic value of the echocardiographic ratio tricuspid annular plane systolic excursion / pulmonary arterial systolic pressure in acute pulmonary embolism
Doctor S. Antit (Tunis, TN)
Abstract Slides Video
Presentation thumbnail
Comparison of conventional and high sensitive cardiac troponin in pulmonary embolism risk assessement
Doctor G. Ferreira (Viseu, PT)
Abstract Slides Video
Presentation thumbnail
Prognostic nutritional index: as a new predictor of mortality in pulmonary arterial hypertension Patients
Professor H. Gungor (Aydin, TR)
Abstract Slides Video
Presentation thumbnail
Assessing invasive hemodynamics in pulmonary hypertension: examining the predictive utility of Ca 125 and NT-proBNP
Doctor N. Ilchyshyn (Almada, PT)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in valvular and pulmonary 2

The Event

Event poster

Heart Failure 2024

11 May 2024 12:12 CET
You may be interested in
thumbnail
Congress Presentation
Impact of new definition on the prognosis of patients with pulmonary hypertension compared to classic definition
thumbnail
Congress Presentation
The impact of the 2022 definition of pulmonary hypertension on long-term clinical outcomes in patients with heart failure with preserved ejection fraction
thumbnail
Congress Presentation
Impact of the 2022 ESC/ERS guidelines on diagnosing pulmonary hypertension in heart failure with reduced ejection fraction patients undergoing elective right heart catheterization

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources